{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:14:06Z","timestamp":1773868446898,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Hospital","doi-asserted-by":"publisher","award":["SA11204"],"award-info":[{"award-number":["SA11204"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jiph.2025.103075","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:05:35Z","timestamp":1764432335000},"page":"103075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genomic evolution and epidemiological impact of SARS-CoV-2 omicron subvariants in Taiwan, 2023\u20132025"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7993-7263","authenticated-orcid":false,"given":"Li-Teh","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-5966","authenticated-orcid":false,"given":"Chao-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Chih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Chang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4062-1958","authenticated-orcid":false,"given":"Ching-Yi","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1656-7188","authenticated-orcid":false,"given":"Chen-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2226-8916","authenticated-orcid":false,"given":"Jih-Jin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jiph.2025.103075_bib1","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/j.jiph.2025.103075_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41579-023-01003-z","article-title":"SARS-CoV-2 biology and host interactions","volume":"22","author":"Steiner","year":"2024","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103075_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2485840","article-title":"From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine","volume":"21","author":"Akingbola","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jiph.2025.103075_bib4","unstructured":"World Health Organization. Tracking SARS-CoV-2 variants. 2025. Available from: \u3008https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/\u3009. Accessed 9 May, 2025."},{"issue":"1","key":"10.1016\/j.jiph.2025.103075_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gch2.1018","article-title":"Data, disease and diplomacy: GISAID's innovative contribution to global health","volume":"1","author":"Elbe","year":"2017","journal-title":"Glob Chall"},{"key":"10.1016\/j.jiph.2025.103075_bib6","article-title":"Identification and Analysis of SARS-CoV-2 Alpha Variants in the Largest Taiwan COVID-19 Outbreak in 2021","volume":"9","author":"Liu","year":"2022","journal-title":"Front Med"},{"issue":"12","key":"10.1016\/j.jiph.2025.103075_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22436","article-title":"The emergence and successful elimination of SARS-CoV-2 dominant strains with increasing epidemic potential in Taiwan's 2021 outbreak","volume":"9","author":"Yang","year":"2023","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.jiph.2025.103075_bib8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jfma.2023.05.027","article-title":"Epidemiological characteristics of the three waves of COVID-19 epidemic in Taiwan during April 2022 to March 2023","volume":"122","author":"Chen","year":"2023","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"10.1016\/j.jiph.2025.103075_bib9","article-title":"Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan","volume":"13","author":"Liu","year":"2023","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jiph.2025.103075_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.102556","article-title":"The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan","volume":"17","author":"Tsai","year":"2024","journal-title":"J Infect Public Health"},{"issue":"2857","key":"10.1016\/j.jiph.2025.103075_bib11","article-title":"Isolation and Identification of a Rare Spike Gene Double-Deletion SARS-CoV-2 Variant From the Patient With High Cycle Threshold Value","volume":"8","author":"Liu","year":"2022","journal-title":"Front Med"},{"issue":"6","key":"10.1016\/j.jiph.2025.103075_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/kjm2.12665","article-title":"The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan","volume":"39","author":"Liu","year":"2023","journal-title":"Kaohsiung J Med Sci"},{"issue":"11","key":"10.1016\/j.jiph.2025.103075_bib13","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","article-title":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology","volume":"5","author":"Rambaut","year":"2020","journal-title":"Nat Microbiol"},{"issue":"67","key":"10.1016\/j.jiph.2025.103075_bib14","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.21105\/joss.03773","article-title":"Nextclade: clade assignment, mutation calling and quality control for viral genomes","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J Open Source Softw"},{"issue":"4","key":"10.1016\/j.jiph.2025.103075_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41592-023-01769-3","article-title":"Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations","volume":"20","author":"Gangavarapu","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.jiph.2025.103075_bib16","unstructured":"Taiwan Centers for Disease Control. Taiwan National Infectious Disease Statistics System. 2025. Available from: \u3008https:\/\/nidss.cdc.gov.tw\/en\/Home\/Index\u3009. Accessed 26 April, 2025."},{"key":"10.1016\/j.jiph.2025.103075_bib17","unstructured":"Taiwan Centers for Disease Control. COVID-19 Weekly Report. Taipei, Taiwan 2025. Available from: \u3008https:\/\/www.cdc.gov.tw\/\u3009. Accessed 9 May, 2025."},{"key":"10.1016\/j.jiph.2025.103075_bib18","unstructured":"World Health Organization. Living guidance for clinical management of COVID-19. Geneva, Switzerland. 2021. Updated 23 November, 2021. Available from: \u3008https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2021-2\u3009. Accessed 21 May, 2025."},{"key":"10.1016\/j.jiph.2025.103075_bib19","unstructured":"World Health Organization. Clinical management of COVID-19: Living guideline. Geneva, Switzerland. 2023. Updated 18 August, 2023. Available from: \u3008https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2023.2\u3009. Accessed 21 May, 2025."},{"issue":"7","key":"10.1016\/j.jiph.2025.103075_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00298-6","article-title":"Virological characteristics of the SARS-CoV-2 KP.2 variant","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.jiph.2025.103075_bib21","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/S1473-3099(24)00415-8","article-title":"Genotype to Phenotype Japan C, et al. Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.jiph.2025.103075_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00731-X","article-title":"Virological characteristics of the SARS-CoV-2 XEC variant","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2025.103075_bib23","unstructured":"World Health Organization. COVID-19 Weekly Epidemiological Update - Edition 163. Geneva, Switzerland. 2024. Updated 19 January, 2024. Available from: \u3008https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update---19-january-2024\u3009. Accessed 12 May, 2025."},{"key":"10.1016\/j.jiph.2025.103075_bib24","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker: Summary of Variant Surveillance. Atlanta, GA, USA. 2024. Updated 9 May, 2025. Available from: \u3008https:\/\/covid.cdc.gov\/covid-data-tracker\/#variant-proportions\u3009. Accessed 12 May, 2025."},{"issue":"7","key":"10.1016\/j.jiph.2025.103075_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcae102","article-title":"The emerging challenge of FLiRT variants: KP.1.1 and KP.2 in the global pandemic landscape","volume":"117","author":"Kumar","year":"2024","journal-title":"QJM"},{"key":"10.1016\/j.jiph.2025.103075_bib26","unstructured":"European Centre for Disease Prevention and Control. SARS-CoV-2 variants of concern - Communicable disease threats report (CDTR) - Weekly Bulletin, 31 December 2023 - 6 January 2024, week 1. Solna, Sweden. 2024. Updated 5 January, 2024. Available from: \u3008https:\/\/www.ecdc.europa.eu\/en\/publications-data\/communicable-disease-threats-report-31-december-2023-6-january-2024-week-1\u3009. Accessed 12 May, 2025."},{"key":"10.1016\/j.jiph.2025.103075_bib27","article-title":"Genetic variability of the recombinant SARS-CoV-2 XEC: Is it a new evolutionary dead-end lineage?","volume":"62","author":"Branda","year":"2024","journal-title":"N Microbes N Infect"},{"issue":"4","key":"10.1016\/j.jiph.2025.103075_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115543","article-title":"Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.jiph.2025.103075_bib29","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/S1473-3099(25)00015-5","article-title":"Virological and antigenic characteristics of SARS-CoV-2 variants LF.7.2.1, NP.1, and LP.8.1","volume":"25","author":"Liu","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2025.103075_bib30","doi-asserted-by":"crossref","unstructured":"Figueroa A., Girard B., Edwards D., Nasir A., Johnson K., Hack S., et al. Immunogenicity of JN.1-and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants. medRxiv 2025.05.02.25325954. \u3008https:\/\/www.medrxiv.org\/content\/10.1101\/2025.05.02.25325954v2\u3009. doi: https:\/\/doi.org\/10.1101\/2025.05.02.25325954.","DOI":"10.1101\/2025.05.02.25325954"},{"key":"10.1016\/j.jiph.2025.103075_bib31","unstructured":"The Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), World Health Organization. Statement on the antigen composition of COVID-19 vaccines. Geneva, Switzerland. 2023. Updated 13 December, 2023. Available from: \u3008https:\/\/www.who.int\/news\/item\/13-12-2023-statement-on-the-antigen-composition-of-covid-19-vaccines\u3009. Accessed 12 May, 2025."},{"key":"10.1016\/j.jiph.2025.103075_bib32","unstructured":"Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) 2023 Case Definition. Atlanta, GA, USA. 2023. Updated 28 February, 2023. Available from: \u3008https:\/\/ndc.services.cdc.gov\/case-definitions\/coronavirus-disease-2019-2023\/\u3009. Accessed 10 May, 2025."},{"key":"10.1016\/j.jiph.2025.103075_bib33","unstructured":"Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) 2025 Case Definition. Atlanta, GA, USA. 2025. Updated 5 November, 2024. Available from: \u3008https:\/\/ndc.services.cdc.gov\/case-definitions\/coronavirus-disease-2019-2025\/\u3009. Accessed 10 May, 2025."},{"key":"10.1016\/j.jiph.2025.103075_bib34","unstructured":"The Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), World Health Organization. From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic. Geneva, Switzerland. 2023. Updated 3 May, 2023. Available from: \u3008https:\/\/iris.who.int\/handle\/10665\/367420\u3009. Accessed 12 May, 2025."},{"key":"10.1016\/j.jiph.2025.103075_bib35","unstructured":"Centers for Disease Control and Prevention. Underlying Conditions and the Higher Risk for Severe COVID-19. 2025. Available from: \u3008https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/underlying-conditions.html\u3009. Accessed 10 May, 2025."},{"issue":"6","key":"10.1016\/j.jiph.2025.103075_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ajic.2022.08.033","article-title":"Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance","volume":"51","author":"O'Leary","year":"2023","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jiph.2025.103075_bib37","unstructured":"Centers for Disease Control and Prevention. People with Certain Medical Conditions and COVID-19 Risk Factors. 2025. Available from: \u3008https:\/\/www.cdc.gov\/covid\/risk-factors\/index.html\u3009. Accessed 10 May, 2025."},{"issue":"1","key":"10.1016\/j.jiph.2025.103075_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12890-024-03468-x","article-title":"Risk factors for disease progression and clinical outcomes in patients with COVID-19 in Taiwan: a nationwide population-based cohort study","volume":"25","author":"Kuo","year":"2025","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.jiph.2025.103075_bib39","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/ijms26031263","article-title":"SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies","volume":"26","author":"Alhamlan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiph.2025.103075_bib40","unstructured":"World Health Organization. Coronavirus disease (COVID-19) Epidemiological Updates and Monthly Operational Updates. 2025. Available from: \u3008https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports\u3009. Accessed 10 May, 2025."}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:08:52Z","timestamp":1773842932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125004241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1876034125004241"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103075","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic evolution and epidemiological impact of SARS-CoV-2 omicron subvariants in Taiwan, 2023\u20132025","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103075"}}